| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 43,790 | 46,212 | 47,435 | 47,441 | | Cost of Revenue | 32,272 | 33,292 | 35,039 | 36,209 | | | Gross Profit | 11,518 | 12,920 | 12,396 | 11,232 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 11,867 | 12,661 | 13,832 | 9,837 | | Non Recurring | 261 | 690 | 188 | (51) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (610) | (431) | (1,624) | 1,446 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (110) | (49) | (109) | 48 | | Earnings Before Interest And Taxes | (720) | (480) | (1,733) | 1,494 | | Interest Expense | 1 |
-
|
-
|
-
| | Income Before Tax | (721) | (480) | (1,733) | 1,494 | | Income Tax Expense | (2) | 21 | 17 | 39 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (719) | (501) | (1,750) | 1,455 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (41) | (206) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (719) | (501) | (1,791) | 1,249 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($719) | ($501) | ($1,791) | $1,249 |
|
0.31% Nasdaq 
0.05%
Income Statement
